News

Boston Biomedical Innovation Center success stories with Kantum Pharma


We are thrilled to share with you a new web video we are releasing that highlights our 'Commercialization Coaches' and other services that are ways B-BIC successfully differentiates from other grants.

October 23, 2019

This week the Boston Biomedical Innovation Center (B-BIC) released a new web video that highlights their 'Commercialization Coaches' and other services in which B-BIC successfully differentiates from other grants. Kantum Pharma, dedicated to the prevention and treatment of Acute Kidney Injury, received its first B-BIC pilot grant in 2017. *The Boston Biomedical Innovation Center is a National Center for Accelerated Innovation funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number U54HL119145. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

More News
May 27, 2020

Kantum Pharma highlights new research demonstrating beneficial effects of P2Y14 antagonist in Acute Kidney Injury

Learn More
News
November 4, 2019

Kantum Pharma founder to present preclinical data demonstrating beneficial effects of P2Y14 antagonist in Acute Kidney Injury at the American Society of Nephrology Annual Meeting

Learn More
News
February 20, 2019

The Power of Discovery with Sylvie Breton –Charged Podcast Episode #20


Learn More
News